What tests and evaluations are recommended for a male experiencing difficulties conceiving with his partner?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Male Fertility Testing: Essential Evaluation Protocol

All men in couples unable to conceive after 12 months of unprotected intercourse (or 6 months if female partner >35 years) require a focused fertility evaluation consisting of medical/reproductive history, physical examination, semen analysis, and hormonal assessment. 1, 2

Core Initial Testing

Semen Analysis - The Cornerstone Test

Obtain at least two semen analyses at least one month apart if the first shows abnormalities. 1, 2, 3 A single normal test is sufficient, but abnormal results require confirmation due to biological variability. 1

Critical collection requirements:

  • Abstain from sexual activity for 2-3 days before collection (inadequate abstinence invalidates results) 3
  • Examine within one hour of collection (delayed analysis compromises motility assessment) 3
  • Collect by masturbation or specialized semen collection condoms 3

WHO 2021 reference values (lower limits): 2, 3

  • Volume ≥1.4 mL
  • pH >7.2
  • Sperm concentration ≥16 million/mL
  • Total sperm number ≥39 million per ejaculate
  • Progressive motility ≥30%
  • Total motility ≥42%
  • Normal morphology ≥4.0%
  • Vitality ≥54% live spermatozoa

Critical pitfall: Semen analysis alone cannot distinguish fertile from infertile men—25% of infertility cases remain unexplained despite normal parameters. 3, 4 Laboratory quality varies significantly, as many facilities don't adhere to WHO standardized methods. 3

Physical Examination - Required Components

Assess the following specific findings: 1, 2, 3

  • Testicular size and consistency (normal volume ≥15 mL)
  • Presence and consistency of vas deferens and epididymides
  • Varicocele presence
  • Penis examination
  • Secondary sex characteristics (body habitus, hair distribution)
  • Digital rectal examination

Medical and Reproductive History - Essential Elements

Document these specific factors: 1, 2, 3

  • Frequency and timing of intercourse
  • Duration of infertility and prior fertility
  • Sexual history including erectile/ejaculatory function
  • Childhood illnesses (cryptorchidism, mumps orchitis)
  • Systemic illnesses and medications
  • Environmental/occupational exposures
  • Anabolic steroid use
  • Smoking, alcohol, and recreational drug use
  • Family history of infertility or genetic conditions

Mandatory Additional Testing Based on Initial Findings

Hormonal Evaluation - When Required

Order serum testosterone and FSH in these situations: 1, 2, 3

  • Sperm concentration <10 million/mL (oligozoospermia)
  • Azoospermia (no sperm)
  • Impaired libido or erectile dysfunction
  • Clinical findings suggesting endocrinopathy

If abnormalities detected, also measure LH and prolactin to distinguish primary testicular dysfunction (elevated LH) from secondary hypogonadism (low/normal LH). 5

Genetic Testing - Specific Indications

Order karyotype and Y-chromosome microdeletion testing when: 2, 3

  • Severe oligospermia (<5 million/mL)
  • Azoospermia

This testing is mandatory before assisted reproductive technology, as genetic abnormalities may be transmitted to offspring. 3

Post-Ejaculatory Urinalysis

Order when ejaculate volume <1 mL (except in bilateral vasal agenesis or hypogonadism) to detect retrograde ejaculation. 3

Advanced Testing - Selected Cases

Men with persistent abnormalities require referral to a male reproductive specialist for: 1, 2

  • Transrectal ultrasonography (if ejaculatory duct obstruction suspected)
  • Testicular ultrasound (if physical examination abnormal or azoospermia)
  • Sperm DNA fragmentation testing (controversial—not routinely recommended by current guidelines, but may be considered in recurrent pregnancy loss or failed IVF) 1

Important caveat: Routine measurement of reactive oxygen species is not recommended, as no standardized testing methods exist and validation in high-quality trials is lacking. 1

Critical Health Counseling

Associated Health Risks

Counsel all men with abnormal semen parameters about increased health risks: 2

  • Higher rates of testicular cancer
  • Increased overall cancer risk
  • Increased mortality compared to fertile men

This makes the fertility evaluation an opportunity for broader health screening.

Lifestyle Modification - Specific Interventions

Address these modifiable factors: 2, 3

  • Smoking cessation (oxidative stress damages sperm DNA)
  • Weight optimization (obesity impairs spermatogenesis)
  • Discontinue anabolic steroids (suppress spermatogenesis)
  • Avoid excessive heat exposure (hot tubs, saunas, laptops on lap)
  • Medication review (many drugs impair fertility)
  • Limit alcohol consumption

Advanced Paternal Age

Counsel couples when male partner ≥40 years about increased risks in offspring, including de novo gene mutations, sperm aneuploidy, and chromosomal aberrations. 2

Simultaneous Partner Evaluation

Both partners must be investigated concurrently—this is a strong recommendation, as male factors contribute to 50% of infertility cases. 1, 6 Delaying male evaluation while focusing solely on the female partner wastes time and resources.

Home Sperm Tests - Limited Role

Home tests serve only as initial screening tools to determine whether formal laboratory evaluation is warranted, particularly for men facing barriers to clinic-based testing. 3 They cannot replace comprehensive semen analysis, as they don't assess morphology and lack quality control. 3 If abnormal, formal laboratory evaluation with two properly performed analyses is mandatory. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Male Fertility Evaluation and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guidelines for Male Infertility Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical assessment of the male fertility.

Obstetrics & gynecology science, 2018

Guideline

Management Approach for Borderline Elevated FSH with Suboptimal Semen Parameters

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.